Bile	Bile	NN	B-NP	O		0	4
resistance	resistance	NN	I-NP	O		5	15
in	in	IN	B-PP	O		16	18
Lactococcus lactis	Lactococcus_lactis	NNP	B-NP	O		19	37
strains	strain	NNS	I-NP	O		38	45
varies	vary	VBZ	B-VP	O		46	52
with	with	IN	B-PP	O		53	57
cellular	cellular	JJ	B-NP	O		58	66
fatty	fatty	JJ	I-NP	O		67	72
acid	acid	NN	I-NP	O		73	77
composition	composition	NN	I-NP	O		78	89
:	:	:	O	O		89	90
analysis	analysis	NN	B-NP	O		91	99
by	by	IN	B-PP	O		100	102
using	use	VBG	B-VP	O		103	108
different	different	JJ	B-NP	O		109	118
growth	growth	NN	I-NP	O		119	125
media	medium	NNS	I-NP	O		126	131
.	.	.	O	O		131	132

Bile	Bile	NN	B-NP	O		133	137
resistance	resistance	NN	I-NP	O		138	148
is	be	VBZ	B-VP	O		149	151
one	one	CD	B-NP	O		152	155
of	of	IN	B-PP	O		156	158
the	the	DT	B-NP	O		159	162
basic	basic	JJ	I-NP	O		163	168
characteristics	characteristic	NNS	I-NP	O		169	184
of	of	IN	B-PP	O		185	187
probiotic	probiotic	JJ	B-NP	O		188	197
bacteria	bacteria	NNS	I-NP	O		198	206
.	.	.	O	O		206	207

The	The	DT	B-NP	O		208	211
aim	aim	NN	I-NP	O		212	215
of	of	IN	B-PP	O		216	218
this	this	DT	B-NP	O		219	223
study	study	NN	I-NP	O		224	229
was	be	VBD	B-VP	O		230	233
to	to	TO	B-VP	O		234	236
investigate	investigate	VB	I-VP	O		237	248
the	the	DT	B-NP	O		249	252
characteristics	characteristic	NNS	I-NP	O		253	268
of	of	IN	B-PP	O		269	271
bile	bile	NN	B-NP	O		272	276
resistance	resistance	NN	I-NP	O		277	287
in	in	IN	B-PP	O		288	290
lactococci	lactococci	NNS	B-NP	O		291	301
by	by	IN	B-PP	O		302	304
studying	study	VBG	B-VP	O		305	313
the	the	DT	B-NP	O		314	317
relationship	relationship	NN	I-NP	O		318	330
between	between	IN	B-PP	O		331	338
bile	bile	NN	B-NP	O		339	343
resistance	resistance	NN	I-NP	O		344	354
and	and	CC	O	O		355	358
cellular	cellular	JJ	B-NP	O		359	367
fatty	fatty	JJ	I-NP	O		368	373
acid	acid	NN	I-NP	O		374	378
composition	composition	NN	I-NP	O		379	390
in	in	IN	B-PP	O		391	393
lactococcci	lactococcci	NNS	B-NP	O		394	405
grown	grow	VBN	B-VP	O		406	411
on	on	IN	B-PP	O		412	414
different	different	JJ	B-NP	O		415	424
media	medium	NNS	I-NP	O		425	430
.	.	.	O	O		430	431

We	We	PRP	B-NP	O		432	434
determined	determine	VBD	B-VP	O		435	445
the	the	DT	B-NP	O		446	449
bile	bile	NN	I-NP	O		450	454
resistance	resistance	NN	I-NP	O		455	465
of	of	IN	B-PP	O		466	468
14	14	CD	B-NP	O		469	471
strains	strain	NNS	I-NP	O		472	479
in	in	IN	B-PP	O		480	482
lactose	lactose	NN	B-NP	O		483	490
-	-	HYPH	B-NP	O		490	491
free	free	JJ	I-NP	O		491	495
M17	M17	NN	I-NP	B-protein		496	499
medium	medium	NN	I-NP	O		500	506
supplemented	supplement	VBN	B-VP	O		507	519
with	with	IN	B-PP	O		520	524
either	either	DT	B-NP	O		525	531
glucose	glucose	NN	I-NP	O		532	539
only	only	RB	B-ADVP	O		540	544
(	(	(	O	O		545	546
GM17	GM17	NN	B-NP	B-protein		546	550
)	)	)	O	O		550	551
or	or	CC	O	O		552	554
lactose	lactose	NN	O	O		555	562
only	only	RB	O	O		563	567
(	(	(	O	O		568	569
LM17	LM17	NN	B-NP	B-protein		569	573
)	)	)	O	O		573	574
.	.	.	O	O		574	575

Gas	Gas	IN	B-PP	O		576	579
chromatographic	chromatographic	JJ	B-NP	O		580	595
analyses	analysis	NNS	I-NP	O		596	604
of	of	IN	B-PP	O		605	607
free	free	JJ	B-NP	O		608	612
lipids	lipid	NNS	I-NP	O		613	619
extracted	extract	VBN	B-VP	O		620	629
from	from	IN	B-PP	O		630	634
the	the	DT	B-NP	O		635	638
tested	test	VBN	I-NP	O		639	645
strains	strain	NNS	I-NP	O		646	653
were	be	VBD	B-VP	O		654	658
used	use	VBN	I-VP	O		659	663
for	for	IN	B-PP	O		664	667
determining	determine	VBG	B-VP	O		668	679
their	their	PRP$	B-NP	O		680	685
fatty	fatty	JJ	I-NP	O		686	691
acid	acid	NN	I-NP	O		692	696
composition	composition	NN	I-NP	O		697	708
.	.	.	O	O		708	709

A	A	DT	B-NP	O		710	711
correlation	correlation	NN	I-NP	O		712	723
analysis	analysis	NN	I-NP	O		724	732
of	of	IN	B-PP	O		733	735
all	all	DT	B-NP	O		736	739
strains	strain	NNS	I-NP	O		740	747
grown	grow	VBN	B-VP	O		748	753
in	in	IN	B-PP	O		754	756
both	both	DT	B-NP	O		757	761
media	medium	NNS	I-NP	O		762	767
revealed	reveal	VBD	B-VP	O		768	776
significant	significant	JJ	B-NP	O		777	788
positive	positive	JJ	I-NP	O		789	797
correlations	correlation	NNS	I-NP	O		798	810
between	between	IN	B-PP	O		811	818
bile	bile	NN	B-NP	O		819	823
resistance	resistance	NN	I-NP	O		824	834
and	and	CC	O	O		835	838
relative	relative	JJ	B-NP	O		839	847
contents	content	NNS	I-NP	O		848	856
of	of	IN	B-PP	O		857	859
hexadecanoic	hexadecanoic	JJ	B-NP	O		860	872
acid	acid	NN	I-NP	O		873	877
and	and	CC	O	O		878	881
octadecenoic	octadecenoic	JJ	B-NP	O		882	894
acid	acid	NN	I-NP	O		895	899
,	,	,	O	O		899	900
and	and	CC	O	O		901	904
negative	negative	JJ	B-NP	O		905	913
correlations	correlation	NNS	I-NP	O		914	926
between	between	IN	B-PP	O		927	934
bile	bile	NN	B-NP	O		935	939
resistance	resistance	NN	I-NP	O		940	950
and	and	CC	O	O		951	954
relative	relative	JJ	B-NP	O		955	963
contents	content	NNS	I-NP	O		964	972
of	of	IN	B-PP	O		973	975
hexadecenoic	hexadecenoic	JJ	B-NP	O		976	988
acid	acid	NN	I-NP	O		989	993
and	and	CC	I-NP	O		994	997
C	C	NN	I-NP	O		998	999
-19	-19	CD	I-NP	O		999	1002
cyclopropane	cyclopropane	NN	I-NP	O		1003	1015
fatty	fatty	JJ	I-NP	O		1016	1021
acid	acid	NN	I-NP	O		1022	1026
.	.	.	O	O		1026	1027

It	It	PRP	B-NP	O		1028	1030
is	be	VBZ	B-VP	O		1031	1033
also	also	RB	B-ADVP	O		1034	1038
a	a	DT	B-NP	O		1039	1040
fact	fact	NN	I-NP	O		1041	1045
that	that	IN	B-SBAR	O		1046	1050
the	the	DT	B-NP	O		1051	1054
fatty	fatty	JJ	I-NP	O		1055	1060
acids	acid	NNS	I-NP	O		1061	1066
associated	associate	VBN	B-VP	O		1067	1077
with	with	IN	B-PP	O		1078	1082
bile	bile	NN	B-NP	O		1083	1087
resistance	resistance	NN	I-NP	O		1088	1098
depended	depend	VBD	B-VP	O		1099	1107
on	on	IN	B-PP	O		1108	1110
species	specie	NNS	B-NP	O		1111	1118
,	,	,	O	O		1118	1119
strain	strain	NN	B-NP	O		1120	1126
,	,	,	O	O		1126	1127
and	and	CC	O	O		1128	1131
/	/	SYM	B-NP	O		1131	1132
or	or	CC	O	O		1132	1134
growth	growth	NN	B-NP	O		1135	1141
medium	medium	NN	I-NP	O		1142	1148
.	.	.	O	O		1148	1149

In	In	IN	B-PP	O		1150	1152
L. lactis	L._lactis	NNP	B-NP	O		1153	1162
subsp.	subsp.	NN	I-NP	O		1163	1169
cremoris	cremoris	NN	I-NP	O		1170	1178
strains	strain	NNS	I-NP	O		1179	1186
grown	grow	VBN	B-VP	O		1187	1192
in	in	IN	B-PP	O		1193	1195
GM17	GM17	NN	B-NP	O		1196	1200
medium	medium	NN	I-NP	O		1201	1207
,	,	,	O	O		1207	1208
the	the	DT	B-NP	O		1209	1212
bile	bile	NN	I-NP	O		1213	1217
-	-	HYPH	O	O		1217	1218
resistant	resistant	JJ	B-NP	O		1218	1227
strains	strain	NNS	I-NP	O		1228	1235
had	have	VBD	B-VP	O		1236	1239
significantly	significantly	RB	B-NP	O		1240	1253
more	more	RBR	I-NP	O		1254	1258
octadecenoic	octadecenoic	JJ	I-NP	O		1259	1271
acid	acid	NN	I-NP	O		1272	1276
than	than	IN	B-PP	O		1277	1281
the	the	DT	B-NP	O		1282	1285
bile	bile	NN	I-NP	O		1286	1290
-	-	HYPH	B-NP	O		1290	1291
sensitive	sensitive	JJ	I-NP	O		1291	1300
strains	strain	NNS	I-NP	O		1301	1308
.	.	.	O	O		1308	1309

In	In	IN	B-PP	O		1310	1312
LM17	LM17	NN	B-NP	O		1313	1317
medium	medium	NN	I-NP	O		1318	1324
,	,	,	O	O		1324	1325
bile	bile	NN	B-NP	O		1326	1330
-	-	HYPH	O	O		1330	1331
resistant	resistant	JJ	B-NP	O		1331	1340
strains	strain	NNS	I-NP	O		1341	1348
had	have	VBD	B-VP	O		1349	1352
significantly	significantly	RB	B-NP	O		1353	1366
more	more	RBR	I-NP	O		1367	1371
octadecenoic	octadecenoic	JJ	I-NP	O		1372	1384
acid	acid	NN	I-NP	O		1385	1389
and	and	CC	O	O		1390	1393
significantly	significantly	RB	B-NP	O		1394	1407
less	less	JJR	I-NP	O		1408	1412
C	C	NN	I-NP	O		1413	1414
-19	-19	CD	I-NP	O		1414	1417
cyclopropane	cyclopropane	NN	I-NP	O		1418	1430
fatty	fatty	JJ	I-NP	O		1431	1436
acid	acid	NN	I-NP	O		1437	1441
than	than	IN	B-PP	O		1442	1446
the	the	DT	B-NP	O		1447	1450
bile	bile	NN	I-NP	O		1451	1455
-	-	HYPH	B-NP	O		1455	1456
sensitive	sensitive	JJ	I-NP	O		1456	1465
strains	strain	NNS	I-NP	O		1466	1473
.	.	.	O	O		1473	1474

In	In	IN	B-PP	O		1475	1477
L. lactis	L._lactis	NNP	B-NP	O		1478	1487
subsp.	subsp.	NN	I-NP	O		1488	1494
lactis	lactis	NN	I-NP	O		1495	1501
strains	strain	NNS	I-NP	O		1502	1509
,	,	,	O	O		1509	1510
bile	bile	NN	B-NP	O		1511	1515
resistances	resistance	NNS	I-NP	O		1516	1527
of	of	IN	B-PP	O		1528	1530
some	some	DT	B-NP	O		1531	1535
of	of	IN	B-PP	O		1536	1538
the	the	DT	B-NP	O		1539	1542
tested	test	VBN	I-NP	O		1543	1549
strains	strain	NNS	I-NP	O		1550	1557
were	be	VBD	B-VP	O		1558	1562
altered	alter	VBN	I-VP	O		1563	1570
by	by	IN	B-PP	O		1571	1573
growth	growth	NN	B-NP	O		1574	1580
medium	medium	NN	I-NP	O		1581	1587
.	.	.	O	O		1587	1588

Some	Some	DT	B-NP	O		1589	1593
strains	strain	NNS	I-NP	O		1594	1601
were	be	VBD	B-VP	O		1602	1606
resistant	resistant	JJ	B-ADJP	O		1607	1616
to	to	TO	B-PP	O		1617	1619
bile	bile	NN	B-NP	O		1620	1624
in	in	IN	B-PP	O		1625	1627
GM17	GM17	NN	B-NP	O		1628	1632
medium	medium	NN	I-NP	O		1633	1639
but	but	CC	O	O		1640	1643
sensitive	sensitive	JJ	B-ADJP	O		1644	1653
to	to	TO	B-PP	O		1654	1656
bile	bile	NN	B-NP	O		1657	1661
in	in	IN	B-PP	O		1662	1664
LM17	LM17	NN	B-NP	B-protein		1665	1669
medium	medium	NN	I-NP	O		1670	1676
.	.	.	O	O		1676	1677

Some	Some	DT	B-NP	O		1678	1682
strains	strain	NNS	I-NP	O		1683	1690
were	be	VBD	B-VP	O		1691	1695
resistant	resistant	JJ	B-ADJP	O		1696	1705
in	in	IN	B-PP	O		1706	1708
both	both	DT	B-NP	O		1709	1713
media	medium	NNS	I-NP	O		1714	1719
tested	test	VBN	B-VP	O		1720	1726
.	.	.	O	O		1726	1727

The	The	DT	B-NP	O		1728	1731
strains	strain	NNS	I-NP	O		1732	1739
grown	grow	VBN	B-VP	O		1740	1745
in	in	IN	B-PP	O		1746	1748
GM17	GM17	NN	B-NP	O		1749	1753
medium	medium	NN	I-NP	O		1754	1760
had	have	VBD	B-VP	O		1761	1764
significantly	significantly	RB	B-NP	O		1765	1778
more	more	RBR	I-NP	O		1779	1783
hexadecanoic	hexadecanoic	JJ	I-NP	O		1784	1796
acid	acid	NN	I-NP	O		1797	1801
and	and	CC	O	O		1802	1805
octadecenoic	octadecenoic	JJ	B-NP	O		1806	1818
acid	acid	NN	I-NP	O		1819	1823
,	,	,	O	O		1823	1824
and	and	CC	O	O		1825	1828
significantly	significantly	RB	B-NP	O		1829	1842
less	less	RBR	I-NP	O		1843	1847
tetradecanoic	tetradecanoic	JJ	I-NP	O		1848	1861
acid	acid	NN	I-NP	O		1862	1866
,	,	,	O	O		1866	1867
octadecadienoic	octadecadienoic	JJ	B-NP	O		1868	1883
acid	acid	NN	I-NP	O		1884	1888
and	and	CC	O	O		1889	1892
C	C	NN	B-NP	O		1893	1894
-19	-19	CD	I-NP	O		1894	1897
cyclopropane	cyclopropane	NN	I-NP	O		1898	1910
fatty	fatty	JJ	I-NP	O		1911	1916
acid	acid	NN	I-NP	O		1917	1921
than	than	IN	B-PP	O		1922	1926
the	the	DT	B-NP	O		1927	1930
strains	strain	NNS	I-NP	O		1931	1938
grown	grow	VBN	B-VP	O		1939	1944
in	in	IN	B-PP	O		1945	1947
LM17	LM17	NN	B-NP	B-protein		1948	1952
medium	medium	NN	I-NP	O		1953	1959
.	.	.	O	O		1959	1960

In	In	IN	B-PP	O		1961	1963
conclusion	conclusion	NN	B-NP	O		1964	1974
,	,	,	O	O		1974	1975
the	the	DT	B-NP	O		1976	1979
fatty	fatty	JJ	I-NP	O		1980	1985
acid	acid	NN	I-NP	O		1986	1990
compositions	composition	NNS	I-NP	O		1991	2003
of	of	IN	B-PP	O		2004	2006
the	the	DT	B-NP	O		2007	2010
bile	bile	NN	I-NP	O		2011	2015
-	-	HYPH	B-NP	O		2015	2016
resistant	resistant	JJ	I-NP	O		2016	2025
lactococci	lactococci	NNS	I-NP	O		2026	2036
differed	differ	VBD	B-VP	O		2037	2045
from	from	IN	B-PP	O		2046	2050
those	those	DT	B-NP	O		2051	2056
of	of	IN	B-PP	O		2057	2059
the	the	DT	B-NP	O		2060	2063
bile	bile	NN	I-NP	O		2064	2068
-	-	HYPH	B-NP	O		2068	2069
sensitive	sensitive	JJ	I-NP	O		2069	2078
ones	one	NNS	I-NP	O		2079	2083
.	.	.	O	O		2083	2084

More	More	RBR	B-ADVP	O		2085	2089
importantly	importantly	RB	I-ADVP	O		2090	2101
,	,	,	O	O		2101	2102
our	our	PRP$	B-NP	O		2103	2106
data	datum	NNS	I-NP	O		2107	2111
suggest	suggest	VBP	B-VP	O		2112	2119
that	that	IN	B-SBAR	O		2120	2124
altering	alter	VBG	B-VP	O		2125	2133
their	their	PRP$	B-NP	O		2134	2139
fatty	fatty	JJ	I-NP	O		2140	2145
acid	acid	NN	I-NP	O		2146	2150
composition	composition	NN	I-NP	O		2151	2162
(	(	(	O	O		2163	2164
i.e.	i.e.	FW	B-NP	O		2164	2168
increased	increase	VBN	B-NP	O		2169	2178
hexadecanoic	hexadecanoic	JJ	I-NP	O		2179	2191
acid	acid	NN	I-NP	O		2192	2196
and	and	CC	O	O		2197	2200
octadecenoic	octadecenoic	JJ	B-NP	O		2201	2213
acid	acid	NN	I-NP	O		2214	2218
and	and	CC	O	O		2219	2222
decreased	decrease	VBD	B-VP	O		2223	2232
hexadecenoic	hexadecenoic	JJ	B-NP	O		2233	2245
acid	acid	NN	I-NP	O		2246	2250
and	and	CC	O	O		2251	2254
C	C	NN	B-NP	O		2255	2256
-19	-19	CD	I-NP	O		2256	2259
cyclopropane	cyclopropane	NN	I-NP	O		2260	2272
fatty	fatty	JJ	I-NP	O		2273	2278
acid	acid	NN	I-NP	O		2279	2283
)	)	)	O	O		2283	2284
by	by	IN	B-PP	O		2285	2287
changing	change	VBG	B-NP	O		2288	2296
growth	growth	NN	I-NP	O		2297	2303
conditions	condition	NNS	I-NP	O		2304	2314
may	may	MD	B-VP	O		2315	2318
be	be	VB	I-VP	O		2319	2321
a	a	DT	B-NP	O		2322	2323
useful	useful	JJ	I-NP	O		2324	2330
way	way	NN	I-NP	O		2331	2334
to	to	TO	B-VP	O		2335	2337
enhance	enhance	VB	I-VP	O		2338	2345
their	their	PRP$	B-NP	O		2346	2351
bile	bile	NN	I-NP	O		2352	2356
resistance	resistance	NN	I-NP	O		2357	2367
in	in	IN	B-PP	O		2368	2370
lactococci	lactococci	NNS	B-NP	O		2371	2381
.	.	.	O	O		2381	2382

